Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Free Cash Flow: 2012-2024

Historic Free Cash Flow for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Dec 2024 value amounting to $172.3 million.

  • Amphastar Pharmaceuticals' Free Cash Flow rose 2.31% to $47.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $113.3 million, marking a year-over-year decrease of 33.44%. This contributed to the annual value of $172.3 million for FY2024, which is 18.58% up from last year.
  • Per Amphastar Pharmaceuticals' latest filing, its Free Cash Flow stood at $172.3 million for FY2024, which was up 18.58% from $145.3 million recorded in FY2023.
  • Amphastar Pharmaceuticals' 5-year Free Cash Flow high stood at $172.3 million for FY2024, and its period low was $23.4 million during FY2020.
  • For the 3-year period, Amphastar Pharmaceuticals' Free Cash Flow averaged around $127.6 million, with its median value being $145.3 million (2023).
  • As far as peak fluctuations go, Amphastar Pharmaceuticals' Free Cash Flow spiked by 11,209.66% in 2020, and later dropped by 7.64% in 2022.
  • Amphastar Pharmaceuticals' Free Cash Flow (Yearly) stood at $23.4 million in 2020, then soared by 201.30% to $70.5 million in 2021, then decreased by 7.64% to $65.1 million in 2022, then soared by 123.09% to $145.3 million in 2023, then rose by 18.58% to $172.3 million in 2024.